Neural Effects of Intravenous N,N-dimethyltryptamine (DMT)
NCT07693257
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Healthy Participants Study
Interventions
DRUG:
N,N-Dimethyltryptamine (15 mg)
DRUG:
N,N-Dimethyltryptamine (17.5 mg)
Sponsor
Jon Dean